LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

News - Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements

28 July 2020
Proficiency Testing in the COVID-19 pandemic

Blog - Proficiency testing (PT), often known as External Quality Assessment (EQA) in the clinical sector, allows laboratories to assess their measurement processes with test materials that we send them

17 July 2020
LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

15 July 2020
LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

09 July 2020
NML response to the Research and Development Roadmap

News - The National Measurement Laboratory (NML), hosted at LGC, welcomes the publication of the UK government’s Research and Development (R&D) Roadmap with its ongoing commitment to increased investment in R&D to cement the UK’s world-leading position within science and research and support the individuals behind it

03 July 2020
The importance of standardisation of diagnostic measurements in the COVID-19 pandemic

Blog - Dr Jim Huggett, Principal Scientist at the NML at LGC, recently answered some of our questions around why standardised measurement is so important to medicine.

02 July 2020
LGC and Q2 Solutions announce global bioanalytical strategic partnership

News - Will each contribute extensive experience and capabilities in small and large molecule bioanalysis to support customer-centric approach

26 June 2020
LGC food forensic expert honoured by Queen’s University

News - A leading expert in food safety and authenticity, and a longtime partner of IGFS, Michael Walker has received an honorary professorship from Queen’s University Belfast.

26 June 2020
New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes

News - Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS

24 June 2020
COVID-19 recovery trials: Dexamethasone and standardisation

Blog - Dexamethasone has undergone study by a team of scientists at Oxford University as part of their Recovery trial.

19 June 2020